Olanzapine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0517-0955
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0517-0955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container Label (Olanzapine For Injection 2)
This is a product label for sterile single-use vial injections of Olanzapine. The NDC number, 0517095501, is provided and the recommended dosage for this medication is 10 mg/vial. There are instructions for how to use the medication, but they are not legible due to errors. It is recommended to store the medication between 68°F to 77°F, and to use it only with accompanying instructions for reconstitution and administration.*
Carton Labeling (Olanzapine For Injection 3)
This is a label for Olanzapine injection medication. The medication comes in vials, each containing 10 mg of Olanzapine. The vial should be stored at room temperature, between 20-25°C. The medication is for intramuscular use only, and the vial is single-use and sterile. The label also includes the manufacturer's name and location.*
Serialization Label (Olanzapine For Injection 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.